Report Detail

The global smart inhalers market is expected to reach US$ 8,033.21 Mn in 2027 from US$ 1,094.26 Mn in 2018. The smart inhalers market is estimated to grow with a CAGR of 25.5% from 2019-2027.
The market is driven by factors such as increasing levels of air pollution as well as a rise in smoking habits, rising prevalence of asthma, and COPD across the globe and growing geriatric population. However, risks associated with cyber threats and limited knowledge regarding the use of smart inhalers may limit the growth of the market to a certain extent.
Smart inhalers are used for the treatment of respiratory disorders such as asthma and COPD. With each inhalation with the help of an inhaler, the device delivers a decided amount of medication to the lungs. However, in practice, there is limited knowledge regarding the proper use of these inhalers for the management of asthma as well as COPD. Often have difficulty in adapting to the correct inhaler technique, and hence, receive insufficient medication. This applies equally to both metered dose inhalers (MDIs) as well as dry powder inhalers (DPIs), leading to poor disease control along with increased healthcare costs.
Studies reveal due to a patient’s error in drug intake occur approximately 70 percent to 90 percent of the time, which results in only 7 percent to 40 percent of the drug being delivered to the lungs. An error related to the coordination between inhalation and the release of drugs through the drug is a commonly observed error among the patients. Even a short delay can lead to only 20 percent of the medication being delivered to the lungs. Another significant error is not breathing deeply enough, which may cause another 10 percent loss of medication to reach the lungs. Improper inhalation technique causes decreased efficacy through reduced deposition of drug in the lungs, eventually leading to an increase in the rate of disease severity and therefore causing an increase in healthcare costs. Hence, the errors that occur due to improper use of inhalers for the management of asthma and COPD are expected to hinder the growth of the market in the future years.
Global smart inhalers were segmented by product, disorder, and end user. The product segment was segmented as inhalers and nebulizers. On the basis of the disorder, the market is categorized as asthma and chronic obstructive pulmonary disease (COPD). Based on the end user, the market was segmented as home-care settings and hospitals & clinics. During 2018, the home-care settings segment led the smart inhalers market by the end user.
Some of the major primary and secondary sources included in the report for, Saudi Thoracic Society, Food and Drug Administration, The Asthma and Allergy Foundation of America, The Brazilian Institute of Geography and Statistics, The National Health Survey, and others.


1. Introduction

  • 1.1 Scope Of The Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Smart Inhalers Market – By Product
    • 1.3.2 Global Smart Inhalers Market – By Disorder
    • 1.3.3 Global Smart Inhalers Market – By End User
    • 1.3.4 Global Smart Inhalers Market – By Geography

2. Global Smart Inhalers Market – Key Takeaways

    3. Research Methodology

    • 3.1 Coverage
    • 3.2 Secondary Research
    • 3.3 Primary Research

    4. Global Smart Inhalers Market – Market Landscape

    • 4.1 Overview
    • 4.2 PEST Analysis
      • 4.2.1 North America PEST Analysis
      • 4.2.2 Europe PEST Analysis
      • 4.2.3 Asia Pacific PEST Analysis
      • 4.2.4 Middle East & Africa PEST Analysis
      • 4.2.5 South & Central America PEST Analysis

    5. Global Smart Inhalers Market – Key Industry Dynamics

    • 5.1 Key Market Drivers
      • 5.1.1 Increasing Levels Of Air Pollution As Well As Rise In The Smoking Habits
      • 5.1.2 Rising Prevalence Of Asthma And Copd Across The Globe
      • 5.1.3 Growing Geriatric Population
    • 5.2 Key Market Restraints
      • 5.2.1 Risks Associated With Cyber Threats
      • 5.2.2 Limited Knowledge Regarding The Use Of Smart Inhalers
    • 5.3 Key Market Opportunity
      • 5.3.1 Growth In The Global Healthcare Market
    • 5.4 Future Trend
      • 5.4.1 Increasing Acceptance Of Mobile Health Technology
    • 5.5 Impact Analysis

    6. Smart Inhalers Market – Global Analysis

    • 6.1 Global Smart Inhalers Market Revenue Forecasts And Analysis
    • 6.2 Global Smart Inhalers Market, By Geography - Forecasts And Analysis
    • 6.3 Performance Of Key Players
      • 6.3.1 Novartis AG
      • 6.3.2 GlaxoSmithKline plc.

    7. Global Smart Inhalers Market Analysis– By Product

    • 7.1 Overview
    • 7.2 Global Smart Inhalers Market, By Product 2018 & 2027 (%)
    • 7.3 Inhalers Market
      • 7.3.1 Overview
      • 7.3.2 Global Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)
    • 7.4 Nebulizers Market
      • 7.4.1 Overview
      • 7.4.2 Global Nebulizers Market Revenue And Forecasts To 2027 (US$ Mn)

    8. Global Smart Inhalers Market Analysis– By Disorder

    • 8.1 Overview
    • 8.2 Global Smart Inhalers Market, By Disorder 2018 & 2027 (%)
    • 8.3 Asthma Market
      • 8.3.1 Overview
      • 8.3.2 Global Asthma Market Revenue And Forecasts To 2027 (US$ Mn)
    • 8.4 Chronic Obstructive Pulmonary Disease Market
      • 8.4.1 Overview
      • 8.4.2 Global Chronic Obstructive Pulmonary Disease Market Revenue And Forecasts To 2027 (US$ Mn)

    9. Global Smart Inhalers Market Analysis– By End User

    • 9.1 Overview
    • 9.2 Global Smart Inhalers Market, By End User 2018 & 2027 (%)
    • 9.3 Hospitals & Clinics Market
      • 9.3.1 Overview
      • 9.3.2 Global Hospitals & Clinics Market Revenue And Forecasts To 2027 (US$ Mn)
    • 9.4 Home Care Settings Market
      • 9.4.1 Overview
      • 9.4.2 Global Home Care Settings Market Revenue And Forecasts To 2027 (US$ Mn)

    10. Smart Inhalers Market Revenue And Forecasts To 2027 – Geographical Analysis

    • 10.1 North America Smart Inhalers Market Revenue And Forecasts To 2027
      • 10.1.1 North America Smart Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)
      • 10.1.2 North America Smart Inhalers Market Revenue And Forecasts To 2027, By Product (US$ Mn)
      • 10.1.3 North America Smart Inhalers Market Revenue And Forecasts To 2027, By Disorder (US$ Mn)
      • 10.1.4 North America Smart Inhalers Market Revenue And Forecasts To 2027, By End User (US$ Mn)
      • 10.1.5 North America Smart Inhalers Market Revenue And Forecasts To 2027, By Country (%)
      • 10.1.6 US Smart Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)
        • 10.1.6.1 US Smart Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)
        • 10.1.6.2 US Smart Inhalers Market Revenue And Forecasts To 2027, By Product (US$ Mn)
        • 10.1.6.3 US Smart Inhalers Market Revenue And Forecasts To 2027, By Disorder (US$ Mn)
        • 10.1.6.4 US Smart Inhalers Market Revenue And Forecasts To 2027, By End User (US$ Mn)
      • 10.1.7 Canada Smart Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)
        • 10.1.7.1 Canada Smart Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)
        • 10.1.7.2 Canada Smart Inhalers Market Revenue And Forecasts To 2027, By Product (US$ Mn)
        • 10.1.7.3 Canada Smart Inhalers Market Revenue And Forecasts To 2027, By Disorder (US$ Mn)
        • 10.1.7.4 Canada Smart Inhalers Market Revenue And Forecasts To 2027, By End User (US$ Mn)
      • 10.1.8 Mexico Smart Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)
        • 10.1.8.1 Mexico Smart Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)
        • 10.1.8.2 Mexico Smart Inhalers Market Revenue And Forecasts To 2027, By Product (US$ Mn)
        • 10.1.8.3 Mexico Smart Inhalers Market Revenue And Forecasts To 2027, By Disorder (US$ Mn)
        • 10.1.8.4 Mexico Smart Inhalers Market Revenue And Forecasts To 2027, By End User (US$ Mn)
    • 10.2 Europe Smart Inhalers Market Revenue And Forecasts To 2027
      • 10.2.1 Europe Smart Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)
      • 10.2.2 Europe Smart Inhalers Market Revenue And Forecasts To 2027, By Product (US$ Mn)
      • 10.2.3 Europe Smart Inhalers Market Revenue And Forecasts To 2027, By Disorder (US$ Mn)
      • 10.2.4 Europe Smart Inhalers Market Revenue And Forecasts To 2027, By End User (US$ Mn)
      • 10.2.5 Europe Smart Inhalers Market Revenue And Forecasts To 2027, By Country (%)
      • 10.2.6 UK Smart Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)
        • 10.2.6.1 UK Smart Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)
        • 10.2.6.2 UK Smart Inhalers Market Revenue And Forecasts To 2027, By Product (US$ Mn)
        • 10.2.6.3 UK Smart Inhalers Market Revenue And Forecasts To 2027, By Disorder (US$ Mn)
        • 10.2.6.4 UK Smart Inhalers Market Revenue And Forecasts To 2027, By End User (US$ Mn)
      • 10.2.7 Germany Smart Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)
        • 10.2.7.1 Germany Smart Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)
        • 10.2.7.2 Germany Smart Inhalers Market Revenue And Forecasts To 2027, By Product (US$ Mn)
        • 10.2.7.3 Germany Smart Inhalers Market Revenue And Forecasts To 2027, By Disorder (US$ Mn)
        • 10.2.7.4 Germany Smart Inhalers Market Revenue And Forecasts To 2027, By End User (US$ Mn)
      • 10.2.8 France Smart Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)
        • 10.2.8.1 France Smart Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)
        • 10.2.8.2 France Smart Inhalers Market Revenue And Forecasts To 2027, By Product (US$ Mn)
        • 10.2.8.3 France Smart Inhalers Market Revenue And Forecasts To 2027, By Disorder (US$ Mn)
        • 10.2.8.4 France Smart Inhalers Market Revenue And Forecasts To 2027, By End User (US$ Mn)
      • 10.2.9 Italy Smart Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)
        • 10.2.9.1 Italy Smart Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)
        • 10.2.9.2 Italy Smart Inhalers Market Revenue And Forecasts To 2027, By Product (US$ Mn)
        • 10.2.9.3 Italy Smart Inhalers Market Revenue And Forecasts To 2027, By Disorder (US$ Mn)
        • 10.2.9.4 Italy Smart Inhalers Market Revenue And Forecasts To 2027, By End User (US$ Mn)
      • 10.2.10 Spain Smart Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)
        • 10.2.10.1 Spain Smart Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)
        • 10.2.10.2 Spain Smart Inhalers Market Revenue And Forecasts To 2027, By Product (US$ Mn)
        • 10.2.10.3 Spain Smart Inhalers Market Revenue And Forecasts To 2027, By Disorder (US$ Mn)
        • 10.2.10.4 Spain Smart Inhalers Market Revenue And Forecasts To 2027, By End User (US$ Mn)
    • 10.3 Asia Pacific Smart Inhalers Market Revenue And Forecasts To 2027
      • 10.3.1 Asia Pacific Smart Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)
      • 10.3.2 Asia Pacific Smart Inhalers Market Revenue And Forecasts To 2027, By Product (US$ Mn)
      • 10.3.3 Asia Pacific Smart Inhalers Market Revenue And Forecasts To 2027, By Disorder (US$ Mn)
      • 10.3.4 Asia Pacific Smart Inhalers Market Revenue And Forecasts To 2027, By End User (US$ Mn)
      • 10.3.5 Asia Pacific Smart Inhalers Market Revenue And Forecasts To 2027, By Country (%)
      • 10.3.6 Japan Smart Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)
        • 10.3.6.1 Japan Smart Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)
        • 10.3.6.2 Japan Smart Inhalers Market Revenue And Forecasts To 2027, By Product (US$ Mn)
        • 10.3.6.3 Japan Smart Inhalers Market Revenue And Forecasts To 2027, By Disorder (US$ Mn)
        • 10.3.6.4 Japan Smart Inhalers Market Revenue And Forecasts To 2027, By End User (US$ Mn)
      • 10.3.7 China Smart Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)
        • 10.3.7.1 China Smart Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)
        • 10.3.7.2 China Smart Inhalers Market Revenue And Forecasts To 2027, By Product (US$ Mn)
        • 10.3.7.3 China Smart Inhalers Market Revenue And Forecasts To 2027, By Disorder (US$ Mn)
        • 10.3.7.4 China Smart Inhalers Market Revenue And Forecasts To 2027, By End User (US$ Mn)
      • 10.3.8 India Smart Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)
        • 10.3.8.1 India Smart Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)
        • 10.3.8.2 India Smart Inhalers Market Revenue And Forecasts To 2027, By Product (US$ Mn)
        • 10.3.8.3 India Smart Inhalers Market Revenue And Forecasts To 2027, By Disorder (US$ Mn)
        • 10.3.8.4 India Smart Inhalers Market Revenue And Forecasts To 2027, By End User (US$ Mn)
      • 10.3.9 South Korea Smart Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)
        • 10.3.9.1 South Korea Smart Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)
        • 10.3.9.2 South Korea Smart Inhalers Market Revenue And Forecasts To 2027, By Product (US$ Mn)
        • 10.3.9.3 South Korea Smart Inhalers Market Revenue And Forecasts To 2027, By Disorder (US$ Mn)
        • 10.3.9.4 South Korea Smart Inhalers Market Revenue And Forecasts To 2027, By End User (US$ Mn)
      • 10.3.10 Australia Smart Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)
        • 10.3.10.1 Australia Smart Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)
        • 10.3.10.2 Australia Smart Inhalers Market Revenue And Forecasts To 2027, By Product (US$ Mn)
        • 10.3.10.3 Australia Smart Inhalers Market Revenue And Forecasts To 2027, By Disorder (US$ Mn)
        • 10.3.10.4 Australia Smart Inhalers Market Revenue And Forecasts To 2027, By End User (US$ Mn)
    • 10.4 Middle East & Africa Smart Inhalers Market Revenue And Forecasts To 2027
      • 10.4.1 Middle East & Africa Smart Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)
      • 10.4.2 Middle East & Africa Smart Inhalers Market Revenue And Forecasts To 2027, By Product (US$ Mn)
      • 10.4.3 Middle East & Africa Smart Inhalers Market Revenue And Forecasts To 2027, By Disorder (US$ Mn)
      • 10.4.4 Middle East & Africa Smart Inhalers Market Revenue And Forecasts To 2027, By End User (US$ Mn)
      • 10.4.5 Middle East & Africa Smart Inhalers Market Revenue And Forecasts To 2027, By Country (%)
      • 10.4.6 UAE Smart Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)
        • 10.4.6.1 UAE Smart Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)
        • 10.4.6.2 UAE Smart Inhalers Market Revenue And Forecasts To 2027, By Product (US$ Mn)
        • 10.4.6.3 UAE Smart Inhalers Market Revenue And Forecasts To 2027, By Disorder (US$ Mn)
        • 10.4.6.4 UAE Smart Inhalers Market Revenue And Forecasts To 2027, By End User (US$ Mn)
      • 10.4.7 Saudi Arabia Smart Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)
        • 10.4.7.1 Saudi Arabia Smart Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)
        • 10.4.7.2 Saudi Arabia Smart Inhalers Market Revenue And Forecasts To 2027, By Product (US$ Mn)
        • 10.4.7.3 Saudi Arabia Smart Inhalers Market Revenue And Forecasts To 2027, By Disorder (US$ Mn)
        • 10.4.7.4 Saudi Arabia Smart Inhalers Market Revenue And Forecasts To 2027, By End User (US$ Mn)
      • 10.4.8 South Africa Smart Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)
        • 10.4.8.1 South Africa Smart Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)
        • 10.4.8.2 South Africa Smart Inhalers Market Revenue And Forecasts To 2027, By Product (US$ Mn)
        • 10.4.8.3 South Africa Smart Inhalers Market Revenue And Forecasts To 2027, By Disorder (US$ Mn)
        • 10.4.8.4 South Africa Smart Inhalers Market Revenue And Forecasts To 2027, By End User (US$ Mn)
    • 10.5 South And Central America Smart Inhalers Market Revenue And Forecasts To 2027
      • 10.5.1 South And Central America Smart Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)
      • 10.5.2 South And Central America Smart Inhalers Market Revenue And Forecasts To 2027, By Product (US$ Mn)
      • 10.5.3 South And Central America Smart Inhalers Market Revenue And Forecasts To 2027, By Disorder (US$ Mn)
      • 10.5.4 South And Central America Smart Inhalers Market Revenue And Forecasts To 2027, By End User (US$ Mn)
      • 10.5.5 South And Central America Smart Inhalers Market Revenue And Forecasts To 2027, By Country (%)
      • 10.5.6 Argentina Smart Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)
        • 10.5.6.1 Argentina Smart Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)
        • 10.5.6.2 Argentina Smart Inhalers Market Revenue And Forecasts To 2027, By Product (US$ Mn)
        • 10.5.6.3 Argentina Smart Inhalers Market Revenue And Forecasts To 2027, By Disorder (US$ Mn)
        • 10.5.6.4 Argentina Smart Inhalers Market Revenue And Forecasts To 2027, By End User (US$ Mn)
      • 10.5.7 Brazil Smart Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)
        • 10.5.7.1 Brazil Smart Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)
        • 10.5.7.2 Brazil Smart Inhalers Market Revenue And Forecasts To 2027, By Product (US$ Mn)
        • 10.5.7.3 Brazil Smart Inhalers Market Revenue And Forecasts To 2027, By Disorder (US$ Mn)
        • 10.5.7.4 Brazil Smart Inhalers Market Revenue And Forecasts To 2027, By End User (US$ Mn)

      11. Smart Inhalers Market– Industry Landscape

      • 11.1 Overview
      • 11.2 Comparative Company Analysis
      • 11.3 Growth Strategies Done By The Companies In The Market, (%)
      • 11.4 Organic Developments
        • 11.4.1 Overview
      • 11.5 Inorganic Developments
        • 11.5.1 Overview

      12. Smart Inhalers Market–Key Company Profiles

      • 12.1 GlaxoSmithKline plc.
        • 12.1.1 Key Facts
        • 12.1.2 Business Description
        • 12.1.3 Financial Overview
        • 12.1.4 Product Portfolio
        • 12.1.5 SWOT Analysis
        • 12.1.6 Key Developments
      • 12.2 Adherium Limited
        • 12.2.1 Key Facts
        • 12.2.2 Business Description
        • 12.2.3 Financial Overview
        • 12.2.4 Product Portfolio
        • 12.2.5 SWOT Analysis
        • 12.2.6 Key Developments
      • 12.3 Novartis AG
        • 12.3.1 Key Facts
        • 12.3.2 Business Description
        • 12.3.3 Financial Overview
        • 12.3.4 Product Portfolio
        • 12.3.5 SWOT Analysis
        • 12.3.6 Key Developments
      • 12.4 Vectura Group Plc
        • 12.4.1 Key Facts
        • 12.4.2 Business Description
        • 12.4.3 Financial Overview
        • 12.4.1 Product Portfolio
        • 12.4.2 SWOT Analysis
        • 12.4.3 Key Developments
      • 12.5 Cohero Health, Inc.
        • 12.5.1 Key Facts
        • 12.5.2 Business Description
        • 12.5.3 Financial Overview
        • 12.5.4 Product Portfolio
        • 12.5.5 SWOT Analysis
        • 12.5.6 Key Developments
      • 12.6 Crux Product Design Ltd
        • 12.6.1 Key Facts
        • 12.6.2 Business Description
        • 12.6.3 Financial Information
        • 12.6.4 Product Portfolio
        • 12.6.5 SWOT Analysis
        • 12.6.6 Key Developments
      • 12.7 Findair Sp. Z O. O.
        • 12.7.1 Key Facts
        • 12.7.2 Business Description
        • 12.7.3 Financial Overview
        • 12.7.4 Product Portfolio
        • 12.7.5 SWOT Analysis
        • 12.7.6 Key Developments
      • 12.8 Teva Pharmaceutical Industries Ltd.
        • 12.8.1 Key Facts
        • 12.8.2 Business Description
        • 12.8.3 Financial Overview
        • 12.8.4 Product Portfolio
        • 12.8.5 SWOT Analysis
        • 12.8.6 Key Developments
      • 12.9 3m
        • 12.9.1 Key Facts
        • 12.9.2 Business Description
        • 12.9.3 Financial Overview
        • 12.9.4 Product Portfolio
        • 12.9.5 SWOT Analysis
        • 12.9.6 Key Developments
      • 12.10 Amiko Digital Health Limited
        • 12.10.1 Key Facts
        • 12.10.2 Business Description
        • 12.10.3 Financial Overview
        • 12.10.4 Product Portfolio
        • 12.10.5 SWOT Analysis
        • 12.10.6 Key Developments

      13. Appendix

      • 13.1 About The Insight Partners

    Summary:
    Get latest Market Research Reports on Smart Inhalers . Industry analysis & Market Report on Smart Inhalers is a syndicated market report, published as Smart Inhalers Market to 2027 - Global Analysis and Forecasts By Product (Nebulizers and Inhalers); Disorder (Chronic Obstructive Pulmonary Disease (COPD) and Asthma); End User (Home-Care Settings and Hospitals & Clinics) and Geography. It is complete Research Study and Industry Analysis of Smart Inhalers market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $4,550.00
    $6,550.00
    $8,550.00
    3,626.35
    5,220.35
    6,814.35
    4,226.95
    6,084.95
    7,942.95
    695,831.50
    1,001,691.50
    1,307,551.50
    379,561.00
    546,401.00
    713,241.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report